STOCK TITAN

Cencora (NYSE: COR) director receives 557-share restricted stock grant

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cencora, Inc. director Frank Clyburn reported an equity award of common stock. He acquired 557 shares of common stock, described as a grant of restricted stock units, at a reference price of $359.28 per share. The award was received for no cash consideration and is scheduled to vest 100% on the first anniversary of the grant date. Following this grant, his directly held common stock position increased to 1,724 shares.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Clyburn Frank

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2026 A 557 A $359.28 1,724(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Franklin K. Clyburn 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did COR report for Frank Clyburn on this Form 4?

Frank Clyburn reported an acquisition of 557 shares of Cencora common stock as an equity grant. The filing describes these as restricted stock units granted for no cash consideration, increasing his directly held position to 1,724 shares after the transaction.

Was the COR insider transaction a purchase or an award of shares?

The COR insider transaction was an award, not an open-market purchase. Frank Clyburn received 557 restricted stock units of Cencora common stock as a grant for no consideration, reflecting typical equity compensation rather than a cash-funded share purchase.

At what price were Frank Clyburn’s COR shares valued in the Form 4 grant?

The 557-share equity grant to Frank Clyburn was reported at a reference price of $359.28 per Cencora common share. This price provides the valuation basis in the Form 4, even though the filing notes the grant was received for no cash consideration.

How many COR shares does Frank Clyburn hold after the reported Form 4 transaction?

After the reported grant, Frank Clyburn directly holds 1,724 shares of Cencora common stock. This total reflects the addition of 557 shares from the restricted stock unit award disclosed, according to the Form 4 ownership figures following the transaction.

When do Frank Clyburn’s newly granted COR restricted stock units vest?

The restricted stock units granted to Frank Clyburn are scheduled to vest 100% on the first anniversary of the grant date. Until vesting, the award remains subject to this time-based condition as described in the Form 4 footnote disclosure.
Cencora Inc.

NYSE:COR

View COR Stock Overview

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

68.60B
184.84M
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN